Current NDC auxiliary source row compounder:335

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 70168-0620
Product Ndc: 70168-0620
Product Ndc Digits: 701680620
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Testosterone Cypionate/Anastrozole 200/1mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Testosterone Cypionate/Anastrozole 200/1mg/mL
Dosage Form Name: SOLUTION
Route Name: INTRAMUSCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: BSO, LLC
Establishment Name: BSO, LLC
Establishment Fei: [empty]
Substance Name: ANASTROZOLE; TESTOSTERONE CYPIONATE
Active Ingredients Info: 1 mg/1 mL; 200 mg/1 mL
History Active Ingredients Raw: ANASTROZOLE; TESTOSTERONE CYPIONATE
History Active Ingredients Info Raw: 1 mg/1 mL; 200 mg/1 mL
History Dosage Raw: SOLUTION
Dea Schedule: CIII
Package Ndc Raw: 70168-0620-1
Package Ndc: 70168-0620-1
Package Ndc Digits: 7016806201
Package Ndc11: 70168062001
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (70168-0620-1)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:335
Source Row Number: 335
Source Row Hash: 720e97df5d6310f8edb4909213c3ee34ad1fe8f19108e418cc390f86cb0ca910
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "70168-0620",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "BSO, LLC",
    "SUBSTANCENAME": "ANASTROZOLE; TESTOSTERONE CYPIONATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "70168-0620-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Testosterone Cypionate/Anastrozole 200/1mg/mL",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Testosterone Cypionate/Anastrozole 200/1mg/mL",
    "PACKAGEDESCRIPTION": "10 mL in 1 VIAL, MULTI-DOSE (70168-0620-1) ",
    "ACTIVEINGREDIENTSINFO": "1 mg/1 mL; 200 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:335
Source Row Number: 335
Status Scope: package
Lookup Ndc: 70168-0620-1
Lookup Ndc Digits: 7016806201
Product Ndc: 70168-0620
Product Ndc Digits: 701680620
Package Ndc: 70168-0620-1
Package Ndc Digits: 7016806201
Package Ndc11: 70168062001
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 720e97df5d6310f8edb4909213c3ee34ad1fe8f19108e418cc390f86cb0ca910
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20